NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss. Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating. |
Country makes solar affordable worldwidePhotography exhibition by Italian journalist opens in Xi'an2 horses fall and unseat their jockeys in 2nd race at Churchill DownsImperial Chinese wine jar stolen from Belgian museumChongqing Youth Film Project unites global youthCommittee advances bill to let Alabama inmates speak at parole hearingsPromoter stands by Ryan Garcia after a report he tested positive for a banned substanceChina's manufacturing PMI down in AprilAwards give books an exciting chapterNorth Carolina congressional candidate suspends campaign days before primary runoff